Steven P. Coen insider trades: Ginkgo Bioworks Holdings (DNA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Steven reports to the SEC
Open-market buys and sales
26 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 19, 2026 | DNA | ↓ Sell | 766 | $10.14 | $8K | Direct | Oct 21, 2026 (2d) |
| Oct 5, 2026 | DNA | ↓ Sell | 2,403 | $15.00 | $36K | Direct | Oct 7, 2026 (2d) |
| Aug 24, 2026 | DNA | ↓ Sell | 330 | $6.98 | $2K | Direct | Aug 25, 2026 (1d) |
| Jul 17, 2026 | DNA | ↓ Sell | 752 | $7.90 | $6K | Direct | Jul 20, 2026 (3d) |
| May 22, 2026 | DNA | ↓ Sell | 307 | $8.33 | $3K | Direct | May 26, 2026 (4d) |
| Apr 13, 2026 | DNA | ↓ Sell | 33,171 | $6.41 | $213K | Direct | Apr 14, 2026 (1d) |
| Mar 16, 2026 | DNA | ↓ Sell | 708 | $6.74 | $5K | Direct | Mar 18, 2026 (2d) |
| Jan 20, 2026 | DNA | ↓ Sell | 972 | $8.92 | $9K | Direct | Jan 22, 2026 (2d) |
| Dec 15, 2025 | DNA | ↓ Sell | 736 | $8.89 | $7K | Direct | Dec 16, 2025 (1d) |
| Oct 17, 2025 | DNA | ↓ Sell | 1,312 | $13.65 | $18K | Direct | Oct 21, 2025 (4d) |
| Oct 1, 2025 | DNA | ↓ Sell | 5,609 | $15.00 | $84K | Direct | Oct 3, 2025 (2d) |
| Aug 22, 2025 | DNA | ↓ Sell | 310 | $12.40 | $4K | Direct | Aug 26, 2025 (4d) |
| Jul 17, 2025 | DNA | ↓ Sell | 1,084 | $9.84 | $11K | Direct | Jul 21, 2025 (4d) |
| May 21, 2025 | DNA | ↓ Sell | 346 | $7.58 | $3K | Direct | May 22, 2025 (1d) |
| Apr 21, 2025 | DNA | ↓ Sell | 997 | $7.28 | $7K | Direct | Apr 23, 2025 (2d) |
| Mar 4, 2025 | DNA | ↓ Sell | 395 | $7.72 | $3K | Direct | Mar 6, 2025 (2d) |
| Feb 4, 2025 | DNA | ↓ Sell | 367 | $13.44 | $5K | Direct | Feb 6, 2025 (2d) |
| Jan 6, 2025 | DNA | ↓ Sell | 324 | $11.72 | $4K | Direct | Jan 8, 2025 (2d) |
| Dec 4, 2024 | DNA | ↓ Sell | 330 | $9.64 | $3K | Direct | Dec 5, 2024 (1d) |
| Nov 4, 2024 | DNA | ↓ Sell | 333 | $7.58 | $3K | Direct | Nov 6, 2024 (2d) |
| Oct 4, 2024 | DNA | ↓ Sell | 306 | $8.35 | $3K | Direct | Oct 8, 2024 (4d) |
| Sep 12, 2024 | DNA | ↓ Sell | 316 | $6.17 | $2K | Direct | Sep 16, 2024 (4d) |
| Aug 2, 2024 | DNA | ↓ Sell | 17,486 | $0.29 | $5K | Direct | Aug 6, 2024 (4d) |
| Jul 2, 2024 | DNA | ↓ Sell | 13,520 | $0.33 | $4K | Direct | Jul 5, 2024 (3d) |
| Jun 3, 2024 | DNA | ↓ Sell | 13,440 | $0.55 | $7K | Direct | Jun 5, 2024 (2d) |
| May 2, 2024 | DNA | ↓ Sell | 131,928 | $0.84 | $111K | Direct | May 6, 2024 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other DNA insiders
Open-market trades in the last 12 months
About Steven P. Coen's insider trades
Steven P. Coen is See remarks at Ginkgo Bioworks Holdings (DNA). Since May 2, 2024, Steven has reported no open-market purchases and 26 sales worth $564K on SEC Form 4. In the last 12 months: 9 sales ($287K).
Their filings also include option exercises (24 filings), grants and awards (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DNA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.